Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GATC Biotech has agreed to buy Pacific Biosciences (PacBio) RS platform, a single molecule, real-time (SMRT) sequencing technology for use in resolving structural variations and for the detection and confirmation of rare SNPs.
Subscribe to our email newsletter
In addition,GATC Biotech said that the future application to enable direct sequencing of methylated bases will make the system attractive for regulatory studies for the pharmaceutical or diagnostics industry.
Pacific Biosciences, Europe, vice president Terry Pizzie said that Pacific Biosciences has chosen GATC Biotech to be their first European service provider because the company is experienced in applying major sequencing technologies in a broad spectrum of projects and in gearing up new sequencing technologies quickly for lab routines.
GATC Biotech chief technology officer Thomas Pohl said that they were looking forward to offering their customers PacBio’s sequencing platform and are confident that they will be able to offer the SMRT technology to their customers within a short period of time after successful installation.